Aardvark Therapeutics (AARD) Q2 2026 Earnings

May 7Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.99
-0.86
-0.73
-0.6

Details

Expected EPS
-0.876517
Actual EPS
-0.99
Surprise EPS
-0.11
Surprise Percent
-12.95%

Description

⁨Aardvark Therapeutics⁩ (⁦AARD⁩) has reported earnings of ⁦-0.99⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts